Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): Randomised, double-blind, placebo-controlled multicentre trial

Dinesh Khanna, Yannick Allanore, Christopher P. Denton, Masataka Kuwana, Marco Matucci-Cerinic, Janet E. Pope, Tatsuya Atsumi, Radim Bečvár, László Czirják, Eric Hachulla, Tomonori Ishii, Osamu Ishikawa, Sindhu R. Johnson, Ellen De Langhe, Chiara Stagnaro, Valeria Riccieri, Elena Schiopu, Richard M. Silver, Vanessa Smith, Virginia SteenWendy Stevens, Gabriella Szücs, Marie Elise Truchetet, Melanie Wosnitza, Kaisa Laapas, Janethe De Oliveira Pena, Zhen Yao, Frank Kramer, Oliver Distler

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): Randomised, double-blind, placebo-controlled multicentre trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds